Kwanan nan, IPHASE, tare da haɗin gwiwa tare da Makarantar Magunguna ta Perelman a Jami'ar Pennsylvania, co-ya rubuta wata kasida a cikin mujallar Antibody Therapeutics (IF=4.56) mai taken "Ci gaban wani
SOT na 63 ya ƙare daidai, kuma farin cikin IPHASE-US ba zai ƙare ba!An yi nasarar gudanar da taron shekara-shekara na 63 na Ƙungiyar Ƙwararrun Ƙwararru ta Amirka daga Maris 10-14, 2024, a cikin
Gabatarwa zuwa Tritosomes● Ma'anar da MuhimmanciTritosomes su ne na musamman tsarin subcellular da ke da hannu a cikin matakai daban-daban na salon salula, musamman a cikin tsarin hanyoyin rayuwa.
IPHASE, a matsayin jagora a cikin reagents na nazarin halittu don bincike na in vitro na sababbin magunguna, ya ci gaba da gabatar da manyan abubuwan bincike na ƙarshe a fannoni da nau'o'i da yawa dangane da shekarun bincike da ƙwarewar ci gaba.
An gudanar da dandalin Innovation na Yamma karo na uku na BIONNOVA a babban otal ɗin Chengdu Intengible Cultural Expo Park Tivoli Hotel a ranar 30 ga Yuli. Mai da hankali kan gungu na masana'antar harhada magunguna ta yamma, mu
Fata cewa kamfanin zai iya tsayawa kan ruhin kasuwanci na "Quality, Efficiency, Innovation and Integrity", zai zama mafi kyau kuma mafi kyau a nan gaba.
Manajan tallace-tallace yana da haƙuri sosai, mun yi magana game da kwanaki uku kafin mu yanke shawarar yin haɗin gwiwa, a ƙarshe, mun gamsu da wannan haɗin gwiwar!